Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OBETICHOLIC ACID
- Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
- The Effect of Obeticholic Acid in Healthy Volunteers
- Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients With Non-alcoholic Steatohepatitis
- Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
- Obeticholic Acid in Pediatric Subjects With Biliary Atresia
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Patients With PBC
- Testing Obeticholic Acid for Familial Adenomatous Polyposis
- Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants
- Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)
- Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
- Obeticholic Acid for Prevention in Barrett's Esophagus
- Clinical Research of Reducing Medication Regimen for Ursodeoxycholic Acid in Treatment of Stable Primary Biliary Cholangitis
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC
- Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects
- Combination Antiretroviral Therapy (cART) for PBC
- Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT
- Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
- Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
- Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
- Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
- Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers
- Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
- Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
- Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
- Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
- Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
- Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)
- Hepatic Impairment Trial of Obeticholic Acid
- Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
- Obeticholic Acid in Bariatric and Gallstone Disease
- Obeticholic Acid in Bile Acid Diarrhoea
- Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
- The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
- Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
Clinical trials list
click for details